CCL21-Ser in melanoma and lung carcinoma cells suppressed tumor growth by developing blood vessels similar to the high endothelial venules in LNs, leading to an enhanced antitumor immunity by mobilizing naïve lymphocytes to the tumor tissue [18]. The gene discussed is CCL21; the disease is melanoma.